Evidence map›Paper›PMID 24875775›Full record

ArticlePLoS pathogens2014

The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis.

Aline Dumas, Nathalie Amiable, Juan Pablo de Rivero Vaccari, Jae Jin Chae, Robert W Keane, Steve Lacroix, Luc Vallières

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Neural-Cardiac Inflammasome Axis after Traumatic Brain Injury.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Aline DumasAxis of Neuroscience, University Hospital Center of Quebec, Quebec, Quebec, Canada.
Nathalie AmiableAxis of Neuroscience, University Hospital Center of Quebec, Quebec, Quebec, Canada.
Juan Pablo de Rivero VaccariDepartment of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami, Miami, Florida, United States of America.
Jae Jin ChaeMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.
Robert W KeaneDepartment of Physiology and Biophysics, University of Miami, Miami, Florida, United States of America.
Steve LacroixAxis of Neuroscience, University Hospital Center of Quebec, Quebec, Quebec, Canada; Department of Molecular Medicine, Laval University, Quebec, Quebec, Canada.
Luc VallièresAxis of Neuroscience, University Hospital Center of Quebec, Quebec, Quebec, Canada; Department of Molecular Medicine, Laval University, Quebec, Quebec, Canada.
Centre hospitalier universitaire de Québec · CANational Human Genome Research Institute · USNeurological Surgery · USUniversité Laval · CAUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial agents can aggravate inflammatory diseases, such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). An example is pertussis toxin (PTX), a bacterial virulence factor commonly used as an adjuvant to promote EAE, but whose mechanism of action is unclear. We have reported that PTX triggers an IL-6-mediated signaling cascade that increases the number of leukocytes that patrol the vasculature by crawling on its luminal surface. In the present study, we examined this response in mice lacking either TLR4 or inflammasome components and using enzymatically active and inactive forms of PTX. Our results indicate that PTX, through its ADP-ribosyltransferase activity, induces two series of events upstream of IL-6: 1) the activation of TLR4 signaling in myeloid cells, leading to pro-IL-1β synthesis; and 2) the formation of a pyrin-dependent inflammasome that cleaves pro-IL-1β into its active form. In turn, IL-1β stimulates nearby stromal cells to secrete IL-6, which is known to induce vascular changes required for leukocyte adhesion. Without pyrin, PTX does not induce neutrophil adhesion to cerebral capillaries and is less effective at inducing EAE in transgenic mice with encephalitogenic T lymphocytes. This study identifies the first microbial molecule that activates pyrin, a mechanism by which infections may influence MS and a potential therapeutic target for immune disorders.

Indexed as

AnimalsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalInflammasomesInterleukin-1betaInterleukin-6MiceMultiple SclerosisMyeloid CellsNeutrophilsPertussis ToxinT-LymphocytesInflammasomesInterleukin-1betaInterleukin-6Pertussis Toxin

Identifiers

PMID24875775
PMCPMC4038594
OpenAlexW2022765384

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.